Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
DX6KRU
|
||||
| Drug Name |
3-(4-(4-methoxyphenyl)piperazin-1-yl)-1-phenylpropan-1-ol
|
||||
| Synonyms |
CHEMBL444335
|
||||
| Indication | Discovery agent | Investigative | [1587926] | ||
| Formula |
C20H26N2O2
|
||||
| Canonical SMILES |
COc1ccc(cc1)N2CCN(CCC(O)c3ccccc3)CC2
|
||||
| InChI |
InChI=1S/C20H26N2O2/c1-24-19-9-7-18(8-10-19)22-15-13-21(14-16-22)12-11-20(23)17-5-3-2-4-6-17/h2-10,20,23H,11-16H2,1H3
|
||||
| InChIKey |
XJDBPHRIKPQDFL-UHFFFAOYSA-N
|
||||
| Target and Pathway | |||||
| Target(s) | 5-hydroxytryptamine 1A receptor | Target Info | [1587926] | ||
| Sodium-dependent serotonin transporter | Target Info | [1587926] | |||
| NetPath Pathway | TCR Signaling Pathway | ||||
| PANTHER Pathway | Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | ||||
| 5HT1 type receptor mediated signaling pathwayP04373:5HT1 type receptor mediated signaling pathway | |||||
| 5HT2 type receptor mediated signaling pathway | |||||
| 5HT3 type receptor mediated signaling pathway | |||||
| 5HT4 type receptor mediated signaling pathway | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.